OrbiMed’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

OrbiMed’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-208,225	Closed	-$12.9M	–	146
2022 Q1	$12.9M	Sell	208,225 -509,032	-71%	-$31.2M	0.21%	90
2021 Q4	$39.5M	Sell	717,257 -6,200	-0.9%	-$323K	0.51%	56
2021 Q3	$38.1M	Buy	723,457 +492,552	+213%	+$29.2M	0.42%	67
2021 Q2	$15.9M	Hold	230,905	–	–	0.16%	104
2021 Q1	$17.8M	Buy	+230,905	New	+$21.3M	0.17%	104
2018 Q4	–	Sell	-391,631	Closed	-$44M	–	138
2018 Q3	$44M	Sell	391,631 -95,359	-20%	-$10.1M	0.53%	60
2018 Q2	$44.9M	Hold	486,990	–	–	0.54%	54
2018 Q1	$48.6M	Hold	486,990	–	–	0.6%	50
2017 Q4	$45.7M	Sell	486,990 -36,800	-7%	-$3.48M	0.58%	50
2017 Q3	$53.3M	Buy	523,790 +240,290	+85%	+$21M	0.51%	62
2017 Q2	$21.7M	Hold	283,500	–	–	0.23%	79
2017 Q1	$24.4M	Hold	283,500	–	–	0.28%	73
2016 Q4	$18.2M	Sell	283,500 -174,400	-38%	-$10.7M	0.23%	71
2016 Q3	$29.6M	Buy	457,900 +105,200	+30%	+$5.93M	0.34%	65
2016 Q2	$19.6M	Buy	352,700 +122,700	+53%	+$6.17M	0.2%	73
2016 Q1	$9.62M	Hold	230,000	–	–	0.1%	97
2015 Q4	$14.5M	Sell	230,000 -282,900	-55%	-$14.5M	0.13%	80
2015 Q3	$20.9M	Hold	512,900	–	–	0.21%	69
2015 Q2	$26.4M	Buy	+512,900	New	+$27.2M	0.22%	74

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OrbiMed's LKFT Position: Q2 2022 in Review

OrbiMed sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2022, closing a stake of 208,225 shares — an estimated $12.9M sold.

OrbiMed first reported a position in LKFT in Q2 2015 and held it in 19 quarters. The position peaked at $53.3M in Q3 2017. 82 funds tracked by Wall St. Rank hold LKFT as of Q2 2022.

OrbiMed reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2022 after selling out during the quarter.
OrbiMed sold 208,225 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2022, an estimated $12.9M.
OrbiMed first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 19 quarters.
OrbiMed's Lakefront Biotherapeutics American Depositary Shares position peaked at $53.3M in Q3 2017.
82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2022.

Based on OrbiMed's 13F filing for Q2 2022, filed 15 Aug 2022.